Private Institute Briefs

Lab’s Second Journal Debuts The Long Island, N.Y.-based Cold Spring Harbor Laboratory recently began publishing its second journal. Cancer Cells: A Monthly Review made its debut in September, joining Genes and Development, the lab’s 2 1/2-year-old periodical. “The lab has a big, publishing program, but it’s primarily books,” says Paula Kiberstis, Cancer Cells' editor. Kiberstis foresees even more Cold Spring Harbor journals in the pipeline: “The publications

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The Long Island, N.Y.-based Cold Spring Harbor Laboratory recently began publishing its second journal. Cancer Cells: A Monthly Review made its debut in September, joining Genes and Development, the lab’s 2 1/2-year-old periodical. “The lab has a big, publishing program, but it’s primarily books,” says Paula Kiberstis, Cancer Cells' editor. Kiberstis foresees even more Cold Spring Harbor journals in the pipeline: “The publications program is moving in that direction,” she says.

The purpose of the new journal, says its editor, is “to get clinicians who are treating cancer patients to interact and to read a bit more about what molecular biologists are doing in the lab, and vice versa.” The 29 scientists on Cancer Cells advisory editorial board were selected because of their different perspectives on the field; only one, Michael Wigler, is associated with the lab. Although the journal has four staffers, Kiberstis is the only one whose involvement ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies